{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:21:41Z","timestamp":1792815701462,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022238","name":"LabEx DEvweCAN","doi-asserted-by":"publisher","award":["ANR-10-LABX-61"],"award-info":[{"award-number":["ANR-10-LABX-61"]}],"id":[{"id":"10.13039\/501100022238","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["EU H2020-847939-IP-cure-B"],"award-info":[{"award-number":["EU H2020-847939-IP-cure-B"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-17-RHUS-0003"],"award-info":[{"award-number":["ANR-17-RHUS-0003"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.omtn.2023.102112","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T12:12:19Z","timestamp":1703679139000},"page":"102112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Cytosine base editing inhibits hepatitis B virus replication and reduces HBsAg expression in\u00a0vitro and in\u00a0vivo"],"prefix":"10.1016","volume":"35","author":[{"given":"Elena M.","family":"Smekalova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Combe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selam","family":"Dejene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Leboeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Robert","family":"Dorkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan Shuan","family":"Shuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kieft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Alberto","family":"Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Packer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ciaramella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5588-5465","authenticated-orcid":false,"given":"Barbara","family":"Testoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"Gregoire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2245-0083","authenticated-orcid":false,"given":"Fabien","family":"Zoulim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.omtn.2023.102112_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/liv.14851","article-title":"HBV 2021: New therapeutic strategies against an old foe","volume":"41","author":"Roca Suarez","year":"2021","journal-title":"Liver Int."},{"key":"10.1016\/j.omtn.2023.102112_bib2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41573-019-0037-0","article-title":"Therapeutic strategies for hepatitis B virus infection: towards a cure","volume":"18","author":"Fanning","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2023.102112_bib4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/genes10040260","article-title":"Meeting the Challenge of Eliminating Chronic Hepatitis B Infection","volume":"10","author":"Revill","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.omtn.2023.102112_bib5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2468-1253(19)30119-0","article-title":"A global scientific strategy to cure hepatitis B","volume":"4","author":"Revill","year":"2019","journal-title":"Lancet. Gastroenterol. Hepatol."},{"key":"10.1016\/j.omtn.2023.102112_bib6","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3390\/v13081463","article-title":"Mechanism of Hepatitis B Virus cccDNA Formation","volume":"13","author":"Wei","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.omtn.2023.102112_bib7","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jhep.2021.05.013","article-title":"Covalently closed circular DNA: The ultimate therapeutic target for curing HBV infections","volume":"75","author":"Martinez","year":"2021","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.omtn.2023.102112_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220376","article-title":"Genomic modeling of hepatitis B virus integration frequency in the human genome","volume":"14","author":"Podlaha","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2023.102112_bib9","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.3389\/fimmu.2019.02308","article-title":"Toward a Functional Cure for Hepatitis B: The Rationale and Challenges for Therapeutic Targeting of the B Cell Immune Response","volume":"10","author":"Ma","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2023.102112_bib10","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jhep.2016.12.024","article-title":"Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B","volume":"66","author":"Leboss\u00e9","year":"2017","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.omtn.2023.102112_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/srep10833","article-title":"CRISPR\/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus","volume":"5","author":"Ramanan","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2023.102112_bib12","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1016\/j.ymthe.2022.05.013","article-title":"Targeting the hepatitis B cccDNA with a sequence-specific ARCUS nuclease to eliminate hepatitis B virus in\u00a0vivo","volume":"30","author":"Gorsuch","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2023.102112_bib13","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.3390\/v14122654","article-title":"Gene Editing Technologies to Target HBV cccDNA","volume":"14","author":"Martinez","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.omtn.2023.102112_bib14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nbt.4192","article-title":"Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements","volume":"36","author":"Kosicki","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2023.102112_bib15","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41588-021-00838-7","article-title":"Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing","volume":"53","author":"Leibowitz","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2023.102112_bib16","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2023.102112_bib17","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u00b7T to G\u00b7C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2023.102112_bib18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood.2022015825","article-title":"Cytosine base editing enables quadruple-edited allogeneic CART cells for T-ALL","volume":"140","author":"Diorio","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2023.102112_bib19","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.omtn.2020.03.005","article-title":"Permanent Inactivation of HBV Genomes by CRISPR\/Cas9-Mediated Non-cleavage Base Editing","volume":"20","author":"Yang","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2023.102112_bib20","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/hep4.1933","article-title":"Efficient silencing of hepatitis B virus S gene through CRISPR-mediated base editing","volume":"6","author":"Zhou","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.omtn.2023.102112_bib21","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jhep.2017.07.011","article-title":"How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B. Time for an individualised approach?","volume":"67","author":"Rajoriya","year":"2017","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.omtn.2023.102112_bib22","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1111\/febs.13777","article-title":"CRISPR guide RNA design for research applications","volume":"283","author":"Mohr","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.omtn.2023.102112_bib23","doi-asserted-by":"crossref","first-page":"D566","DOI":"10.1093\/nar\/gks1022","article-title":"HBVdb: a knowledge database for Hepatitis B Virus","volume":"41","author":"Hayer","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2023.102112_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-6700-1_1","article-title":"NTCP-Reconstituted In\u00a0Vitro HBV Infection System","volume":"1540","author":"Sun","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2023.102112_bib25","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijpharm.2010.01.019","article-title":"Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells","volume":"389","author":"Zou","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.omtn.2023.102112_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02888-21","article-title":"CRISPR-Cas9 Targeting of Hepatitis B Virus Covalently Closed Circular DNA Generates Transcriptionally Active Episomal Variants","volume":"13","author":"Martinez","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.omtn.2023.102112_bib27","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1136\/gutjnl-2022-328380","article-title":"Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure","volume":"72","author":"Allweiss","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.omtn.2023.102112_bib28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2133\/dmpk.DMPK-10-RG-047","article-title":"In\u00a0vitro evaluation of cytochrome P450 and glucuronidation activities in hepatocytes isolated from liver-humanized mice","volume":"25","author":"Yamasaki","year":"2010","journal-title":"Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.omtn.2023.102112_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41467-017-00200-8","article-title":"Long-term hepatitis B infection in a scalable hepatic co-culture system","volume":"8","author":"Winer","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2023.102112_bib30","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1243462","article-title":"Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA","volume":"343","author":"Lucifora","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.omtn.2023.102112_bib31","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/s41467-020-15887-5","article-title":"Cytosine base editors with minimized unguided DNA and RNA off-target events and high on-target activity","volume":"11","author":"Yu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2023.102112_bib32","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s41587-022-01611-9","article-title":"Improved cytosine base editors generated from TadA variants","volume":"41","author":"Lam","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2023.102112_bib33","doi-asserted-by":"crossref","first-page":"eaan0241","DOI":"10.1126\/scitranslmed.aan0241","article-title":"RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg","volume":"9","author":"Wooddell","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2023.102112_bib34","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jhep.2021.04.051","article-title":"Ubiquitous expression of HBsAg from integrated HBV DNA in patients with low viral load","volume":"75","author":"Meier","year":"2021","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.omtn.2023.102112_bib35","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","article-title":"Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA","volume":"84","author":"Sells","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2023.102112_bib36","first-page":"2124","article-title":"Establishment of a continuously growing cell line from primary carcinoma of the liver","volume":"50","author":"Alexander","year":"1976","journal-title":"S.\u00a0Afr. Med. J."},{"key":"10.1016\/j.omtn.2023.102112_bib37","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3390\/genes11060661","article-title":"Analysis of HBV Genomes Integrated into the Genomes of Human Hepatoma PLC\/PRF\/5 Cells by HBV Sequence Capture-Based Next-Generation Sequencing","volume":"11","author":"Ishii","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.omtn.2023.102112_bib38","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jhep.2017.02.004","article-title":"HBVcircle: A novel tool to investigate hepatitis B virus covalently closed circular DNA","volume":"66","author":"Yan","year":"2017","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.omtn.2023.102112_bib39","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1161\/ATVBAHA.117.309881","article-title":"In\u00a0Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin\/Kexin Type 9) as a Therapeutic Alternative to Genome Editing","volume":"37","author":"Chadwick","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.omtn.2023.102112_bib40","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1472-6750-11-80","article-title":"RNase H-dependent PCR (rhPCR): improved specificity and single nucleotide polymorphism detection using blocked cleavable primers","volume":"11","author":"Dobosy","year":"2011","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.omtn.2023.102112_bib41","article-title":"High-efficiency base editing for Stargardt disease in mice, non-human primates, and human retina tissue","author":"Muller","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2023.102112_bib42","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","article-title":"Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases","volume":"30","author":"Bae","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2023.102112_bib43","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.celrep.2018.02.014","article-title":"A Single Administration of CRISPR\/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In\u00a0Vivo Genome Editing","volume":"22","author":"Finn","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2023.102112_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1609","article-title":"Strategies for nonviral nanoparticle-based delivery of CRISPR\/Cas9 therapeutics","volume":"12","author":"Chen","year":"2020","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.omtn.2023.102112_bib45","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","article-title":"Drug delivery systems for RNA therapeutics","volume":"23","author":"Paunovska","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2023.102112_bib46","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/nar\/gkz093","article-title":"Delivering SaCas9 mRNA by lentivirus-like bionanoparticles for transient expression and efficient genome editing","volume":"47","author":"Lu","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2023.102112_bib47","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/hep.32245","article-title":"HBV covalently closed circular DNA minichromosomes in distinct epigenetic transcriptional states differ in their vulnerability to damage","volume":"75","author":"Wang","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.omtn.2023.102112_bib48","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrgastro.2016.7","article-title":"Global strategies are required to cure and eliminate HBV infection","volume":"13","author":"Revill","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.omtn.2023.102112_bib49","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.3390\/v14092052","article-title":"Oligonucleotide-Based Therapies for Chronic HBV Infection: A Primer on Biochemistry, Mechanisms and Antiviral Effects","volume":"14","author":"Vaillant","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.omtn.2023.102112_bib50","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3350\/cmh.2022.0012","article-title":"RNA interference as a novel treatment strategy for chronic hepatitis B infection","volume":"28","author":"Hui","year":"2022","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.omtn.2023.102112_bib51","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2893.1998.00124.x","article-title":"Structure and function of the encapsidation signal of hepadnaviridae","volume":"5","author":"Kramvis","year":"1998","journal-title":"J.\u00a0Viral Hepat."},{"key":"10.1016\/j.omtn.2023.102112_bib52","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/hep.510270243","article-title":"Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective","volume":"27","author":"Melegari","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.omtn.2023.102112_bib53","article-title":"Spinoculation Enhances HBV Infection in NTCP-Reconstituted Hepatocytes","volume":"10","author":"Yan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2023.102112_bib55","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.ymthe.2022.01.040","article-title":"Evaluation of cytosine base editing and adenine base editing as a potential treatment for alpha-1 antitrypsin deficiency","volume":"30","author":"Packer","year":"2022","journal-title":"Mol. Ther."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225312300330X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225312300330X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:42:47Z","timestamp":1760856167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S216225312300330X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S216225312300330X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2023.102112","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytosine base editing inhibits hepatitis B virus replication and reduces HBsAg expression in\u00a0vitro and in\u00a0vivo","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2023.102112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"102112"}}